|
|
Commentary : pathophysiological role of histamine H4 receptor in cancer : therapeutic implications |
|---|---|
| Author: | Salem, Abdelhakim1,2; Salo, Tuula1,2,3,4 |
| Organizations: |
1Department of Oral and Maxillofacial Diseases, Clinicum, University of Helsinki, Helsinki, Finland 2Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland 3Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland
4Department of Oral Pathology, Helsinki University Hospital (HUS), Helsinki, Finland
|
| Format: | article |
| Version: | published version |
| Access: | open |
| Online Access: | PDF Full Text (PDF, 0.5 MB) |
| Persistent link: | http://urn.fi/urn:nbn:fi-fe2020091069237 |
| Language: | English |
| Published: |
Frontiers Media,
2020
|
| Publish Date: | 2020-09-10 |
| Series: |
Frontiers in pharmacology |
| ISSN: | 1663-9812 |
| ISSN-E: | 1663-9812 |
| ISSN-L: | 1663-9812 |
| Volume: | 11 |
| Pages: | 1 - 3 |
| Article number: | 874 |
| DOI: | 10.3389/fphar.2020.00874 |
| OADOI: | https://oadoi.org/10.3389/fphar.2020.00874 |
| Type of Publication: |
A1 Journal article – refereed |
| Field of Science: |
3122 Cancers |
| Subjects: | |
| Funding: |
This work was supported by Emil Aaltonen Foundation (Emil Aaltosen Säätiö); The Maud Kuistila Memorial Foundation; The Jane and Aatos Erkko Foundation; and Helsinki University Central Hospital (HUS) Research Funds. |
| Copyright information: |
© 2020 Salem and Salo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
|
https://creativecommons.org/licenses/by/4.0/ |